Skip to main content

AnaptysBio Inc. Common Stock (ANAB)

About The Company

ANAB Stock Market Logo

AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements.

IPO Year Sector Industry
2017 Health Care Biotechnology: Pharmaceutical Preparations

AnaptysBio Inc. (ANAB) Latest News

Company Contact & Address (ANAB)

Corporate Headquarters Phone Website
United States
+1 858 362-6295 Official ANAB Website

ANAB Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ANAB

Jobs & Employment at AnaptysBio Inc.

LinkedIn Company Page
Official Career & Employment Page Jobs & Careers at AnaptysBio Inc. (ANAB)

Related & Similar Stock Symbols

DESP Stock Market Price & News

DESP Corp. Ordinary Shares

AMPG Stock Market Price & News


Amplitech Group Inc. Common Stock

CRMD Stock Market Price & News


CorMedix Inc. Common Stock